Clinical Trials

30 enrolled

Multiple Myeloma

NCT00550277 2021-11-23

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

20 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell

NCT00742027 2021-07-28

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

129 enrolled 16 charts

Hodgkin Disease

NCT00667862 2021-06-21

Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer

35 enrolled 8 charts

Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00936611 2021-01-28

LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

39 enrolled 13 charts

Waldenstrom Macroglobulinemia, Recurrence

NCT01013597 2019-11-29

Trial of LBH589 in Metastatic Thyroid Cancer

13 enrolled 11 charts

Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT01523834 2019-11-22

FIL_PanAL10

35 enrolled 10 charts

Lymphoma, Large B-Cell, Diffuse

NCT02290431 2019-11-18

Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma

31 enrolled 19 charts

Multiple Myeloma, Recurrence

NCT01651039 2018-04-09

Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)

32 enrolled 21 charts

Multiple Myeloma

NCT01083602 2017-12-21

MACS1271

55 enrolled 11 charts

Multiple Myeloma, Recurrence

NCT01460940 2017-11-14

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

24 enrolled 7 charts

Hodgkin Disease

NCT00880269 2017-02-23

Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)

Other hematologic neoplasm

59 enrolled 7 charts

Leukemia, Leukemia, Myeloid, Acute

NCT00901147 2014-06-27

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

25 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT01136499 2013-03-06

ESTIM-LBH

53 enrolled

Sarcoma

NCT00690677 2012-01-18

Phase II Trial of LBH589 in Refractory Colorectal Cancer

29 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01222936 2010-10-18

LBH Phase II in Small Cell Lung Cancer (SCLC)